Malaria
Malaria is the disease that most shaped the human genome and still kills a child somewhere in the world roughly every minute. It is caused by single-celled Plasmodium parasites delivered by the bite of a female Anopheles mosquito, and it produces the classic story every clinician learns to fear: a returned traveller or a resident of an endemic region with cyclical fever, sweats, and rigors that, in the case of Plasmodium falciparum, can slide within hours into coma, kidney failure, and death. What makes malaria such a rewarding topic to master is that it rewards clear thinking at every step — the parasite's life cycle explains the fever pattern, the fever pattern hints at the species, the species dictates the drug, and a single blood film can settle the diagnosis in minutes.
For students and exam candidates, malaria sits at the intersection of parasitology, tropical medicine, and acute care. It is a "must not miss" diagnosis: falciparum malaria is a medical emergency, and the phrase worth tattooing on the mind is fever in a returned traveller is malaria until proven otherwise.
Learning Objectives
- Describe the Plasmodium life cycle and link each stage to symptoms, diagnosis, and treatment targets.
- Distinguish the five human malaria species, especially P. falciparum and P. vivax, by biology and severity.
- Recognise the clinical features of uncomplicated versus severe/complicated malaria, including cerebral malaria.
- Diagnose malaria using thick and thin blood films and rapid diagnostic tests, and interpret parasite density.
- Select appropriate treatment — artemisinin-based combination therapy, IV artesunate, and radical cure with primaquine.
- Apply prevention: vector control, chemoprophylaxis, and the newer malaria vaccines.
Quick Answer
Malaria is a parasitic infection caused by five Plasmodium species transmitted by Anopheles mosquitoes; P. falciparum causes most deaths and P. vivax is the most geographically widespread. Sporozoites injected in a bite mature in the liver, then invade red blood cells, and the synchronous rupture of infected cells produces the cyclical fever, chills, and anaemia. Diagnosis rests on microscopy of thick and thin blood films (still the gold standard) or a rapid antigen test, with species identification and parasite density guiding management. Uncomplicated malaria is treated with an artemisinin-based combination therapy (ACT); severe malaria — defined by features such as impaired consciousness, acidosis, severe anaemia, or high parasitaemia — requires immediate intravenous artesunate. P. vivax and P. ovale also need primaquine to clear dormant liver forms (hypnozoites) and prevent relapse, after checking G6PD status. Prevention combines bed nets, indoor spraying, chemoprophylaxis for travellers, and, increasingly, vaccination.
Where It Came From
Malaria is ancient — its name comes from the Italian mal'aria, "bad air", reflecting the old belief that swamp vapours caused the fevers that clustered around marshes. The real culprit was invisible until the germ era. In 1880 the French army surgeon Charles Louis Alphonse Laveran, working in Algeria, peered at the blood of a feverish soldier and saw pigmented, moving parasites inside red cells — the first time a protozoan was shown to cause human disease, earning him a Nobel Prize. The missing link, how it spread, was solved in 1897–1898 when Ronald Ross, working in India, demonstrated that mosquitoes transmit the parasite, and Italian workers led by Giovanni Battista Grassi pinned the vector down to the Anopheles genus. Ross too won a Nobel Prize.
The motivation for all this work was overwhelming: malaria crippled armies, stalled the building of the Panama Canal, and drained the economies of entire regions. That practical need drove one of medicine's great arcs of drug discovery. Quinine, extracted from cinchona bark by South American peoples and brought to Europe by Jesuit missionaries, was the mainstay for centuries. The twentieth century added chloroquine, then watched resistance spread across the globe. The decisive modern breakthrough came from Tu Youyou, who in the 1970s, screening traditional Chinese remedies for a secret military project, isolated artemisinin from sweet wormwood (Artemisia annua) — a discovery that now anchors first-line treatment worldwide and won her the 2015 Nobel Prize. The story of malaria is therefore also the story of how urgent human need turns folk knowledge into rigorous medicine.
The Parasite and Its Life Cycle
Understanding the Plasmodium life cycle is the single most useful thing a student can do, because almost every clinical fact flows from it. The cycle runs across two hosts — a human and a mosquito.
In the human (asexual cycle):
- Sporozoite injection. A feeding female Anopheles injects sporozoites in her saliva. They travel in the blood to the liver within minutes.
- Liver (exo-erythrocytic) stage. Sporozoites invade hepatocytes and multiply silently for about 1–2 weeks. This stage is asymptomatic — which is why symptoms begin only after an incubation period. Crucially, P. vivax and P. ovale can form hypnozoites, dormant liver forms that reactivate weeks to months later and cause relapse.
- Blood (erythrocytic) stage. Merozoites released from the liver invade red blood cells, cycling through ring, trophozoite, and schizont forms. When schizonts rupture, they release new merozoites and cellular debris, triggering the paroxysm of fever, chills, and sweats. The synchrony of this rupture explains the classic periodicity: roughly every 48 hours (tertian) for P. vivax, P. ovale, and P. falciparum, and every 72 hours (quartan) for P. malariae.
- Gametocytes. Some parasites differentiate into male and female sexual forms that circulate in the blood, ready to infect the next mosquito.
In the mosquito (sexual cycle): ingested gametocytes fuse, form an oocyst on the gut wall, and produce new sporozoites that migrate to the salivary glands — completing the cycle.
Two consequences deserve emphasis. First, drugs act on different stages: schizonticides (like ACTs) kill the blood forms that cause illness, while primaquine and tafenoquine kill the liver hypnozoites that cause relapse. Second, P. falciparum infects red cells of all ages and makes infected cells cytoadhere to blood-vessel walls (sequestration), which is why it causes the highest parasite loads and the deadly microvascular complications of severe malaria.
The Five Species and Why They Differ
| Feature | P. falciparum | P. vivax | P. ovale | P. malariae | P. knowlesi |
|---|---|---|---|---|---|
| Main region | Sub-Saharan Africa | Asia, Latin America | West Africa | Worldwide, patchy | Southeast Asia |
| Severity | Most severe, kills | Usually milder | Mild | Chronic, low-grade | Can be severe |
| Relapse (hypnozoites) | No | Yes | Yes | No | No |
| Fever cycle | Tertian (often irregular) | Tertian | Tertian | Quartan | Daily (24 h) |
| Red cells infected | All ages | Young cells only | Young cells | Old cells | All ages |
| Notable point | Cerebral malaria, high parasitaemia | Commonest cause of relapse | Similar to vivax | Can cause nephrotic syndrome | Rapid, monkey reservoir |
The practical takeaways: P. falciparum is the killer and the one that turns severe; P. vivax and P. ovale relapse and need radical cure; P. malariae can smoulder for years and rarely damages the kidney; and P. knowlesi, a monkey parasite, multiplies every 24 hours and can deteriorate fast, so it should not be dismissed as trivial.
Clinical Features: Uncomplicated and Severe
Uncomplicated malaria presents non-specifically — this is the trap. Fever is the constant, but the textbook cold-hot-sweating paroxysm is often absent, especially early. Patients report headache, myalgia, fatigue, nausea, and sometimes diarrhoea, and are easily mislabelled as having "flu" or gastroenteritis. Examination may show only fever and a mildly enlarged spleen. Mild anaemia and thrombocytopenia are common clues on the blood count — a febrile traveller with a low platelet count should make you think of malaria.
Severe/complicated malaria is almost always P. falciparum (occasionally P. vivax or P. knowlesi) and is defined by organ dysfunction or high parasite burden. Learn these features, because any one of them changes management to IV artesunate and intensive care:
- Cerebral malaria — impaired consciousness, coma, or seizures. Mortality is high even when treated.
- Severe anaemia from massive red-cell destruction.
- Acute kidney injury ("blackwater fever" with haemoglobinuria in classic cases).
- Metabolic acidosis and respiratory distress — an ominous sign, especially in children.
- Hypoglycaemia — from the parasite and from quinine-stimulated insulin release.
- Acute respiratory distress syndrome and pulmonary oedema.
- Hyperparasitaemia (commonly defined as more than 5–10% of red cells infected).
- Shock, spontaneous bleeding/DIC, and jaundice.
A worked clinical vignette
A 34-year-old returns to a temperate country 10 days after a business trip to Nigeria. He took no chemoprophylaxis. For three days he has had fever to 39.5°C, headache, and worsening drowsiness. On arrival he is confused (unable to say the date), tachycardic, and jaundiced. Bloods show haemoglobin 8.2 g/dL, platelets 40,000, creatinine rising, and a lactate of 5 mmol/L. A thick film shows P. falciparum with 8% parasitaemia.
Reasoning: This is severe falciparum malaria — he has impaired consciousness (cerebral malaria), acidosis (high lactate), acute kidney injury, and hyperparasitaemia. He needs immediate IV artesunate, glucose monitoring for hypoglycaemia, careful fluid balance (over-resuscitation worsens outcomes), and admission to critical care. Do not wait for species confirmation beyond the film; do not use oral therapy in a vomiting, drowsy patient. This case captures why malaria is an emergency: he was well a week ago.
Diagnosis: The Blood Film and Beyond
- Thick and thin blood films (microscopy) remain the gold standard. The thick film concentrates parasites and is best for detection and counting density; the thin film preserves cell morphology and is best for species identification. A single negative film does not exclude malaria — repeat every 12–24 hours over 48–72 hours if suspicion persists, because parasitaemia fluctuates with the cycle.
- Rapid diagnostic tests (RDTs) detect parasite antigens (HRP-2 for falciparum, or pan-species LDH/aldolase) from a fingerprick in minutes. They are invaluable where microscopy is unavailable, but they do not quantify parasitaemia, can miss low-density infection, and HRP-2 can stay positive for weeks after cure. Some falciparum strains have deleted the hrp2 gene and give false negatives.
- PCR is the most sensitive and best for species confirmation and mixed infections but is slower and used mainly in reference or research settings.
- Supportive labs — thrombocytopenia, anaemia, elevated LDH and bilirubin (haemolysis), glucose, lactate, creatinine — help grade severity.
Treatment Principles
Treatment depends on species, severity, and local resistance patterns.
- Uncomplicated falciparum malaria: an artemisinin-based combination therapy (ACT) — e.g. artemether-lumefantrine or dihydroartemisinin-piperaquine. Combining a fast-acting artemisinin with a longer-acting partner drug clears parasites quickly and protects against resistance.
- Uncomplicated vivax/ovale malaria: chloroquine still works in many areas (ACT where chloroquine resistance exists), plus primaquine to eradicate hypnozoites and prevent relapse — the "radical cure". Check G6PD status first, because primaquine (and tafenoquine) cause severe haemolysis in G6PD deficiency.
- Severe malaria (any species): intravenous artesunate is the drug of choice worldwide — it is superior to IV quinine and reduces mortality. Transition to a full oral ACT course once the patient can tolerate it. Watch for delayed post-artesunate haemolysis in the weeks after treatment.
- Supportive care in severe disease: treat hypoglycaemia, manage seizures, transfuse for severe anaemia, support the kidneys, and avoid aggressive fluid boluses (the FEAST trial showed boluses increased mortality in African children).
Real-World Applications
- Travel medicine: advising a traveller to sub-Saharan Africa on chemoprophylaxis (atovaquone-proguanil, doxycycline, or mefloquine), bite avoidance, and prompt testing if fever develops within a year of return.
- Emergency and acute medicine: every febrile returned traveller needs a malaria film that day — the diagnosis is missed when clinicians forget to ask about travel.
- Global public health: distribution of insecticide-treated bed nets, indoor residual spraying, seasonal chemoprevention in children, and rollout of the RTS,S/AS01 (Mosquirix) and R21/Matrix-M vaccines, the first vaccines against any human parasite.
- Obstetrics: malaria in pregnancy causes placental infection, maternal anaemia, and low birth weight, so intermittent preventive treatment is a core antenatal intervention in endemic regions.
- Blood safety and migration medicine: screening donors and migrants from endemic areas, since P. malariae can persist silently for decades.
Common Mistakes
-
"The film was negative, so it isn't malaria." Why it's wrong: parasitaemia fluctuates with the erythrocytic cycle and may be below the detection threshold at any single moment. Correction: a single negative film never excludes malaria — repeat two or three films over 48–72 hours before ruling it out.
-
Treating severe malaria with oral drugs, or waiting for definitive species results. Why it's wrong: falciparum can kill within hours, and a drowsy or vomiting patient will not absorb oral medication. Correction: if there are any severity features, give IV artesunate immediately based on the initial film.
-
Giving primaquine without checking G6PD status. Why it's wrong: primaquine triggers life-threatening haemolysis in G6PD-deficient patients. Correction: always test G6PD before radical cure, and never use primaquine in pregnancy.
-
Assuming vivax malaria is always benign. Why it's wrong: P. vivax can cause severe anaemia and, occasionally, severe disease, and it relapses if hypnozoites are not cleared. Correction: treat the blood stage and give radical cure, and monitor for complications.
-
Aggressive fluid boluses in severe malaria. Why it's wrong: rapid fluid loading increases mortality and precipitates pulmonary oedema. Correction: use cautious, guided fluid management.
Comparison and Connections
Malaria is often confused with other causes of fever in travellers, so it helps to anchor it against neighbours. Dengue also causes fever, thrombocytopenia, and myalgia but classically brings retro-orbital pain and a rash and does not respond to antimalarials — see Dengue Fever. Enteric fever (typhoid) produces prolonged fever with relative bradycardia and abdominal symptoms. Sepsis from any source can mimic severe malaria and, importantly, can coexist with it — see Sepsis and Septic Shock.
| Concept | Malaria | Dengue |
|---|---|---|
| Pathogen | Plasmodium protozoa | Flavivirus |
| Vector | Anopheles mosquito (night-biting) | Aedes mosquito (day-biting) |
| Hallmark labs | Anaemia, low platelets, haemolysis | Low platelets, haemoconcentration, leukopenia |
| Danger phase | Cerebral/organ failure (falciparum) | Plasma leakage/shock (defervescence) |
| Specific treatment | ACT / IV artesunate | Supportive only |
The parasite's biology also connects to human genetics: sickle cell trait, thalassaemia, and G6PD deficiency all persist at high frequency in endemic regions because they confer partial protection against falciparum malaria — one of the clearest examples of natural selection in humans. See also Microbiology for parasite classification and Pharmacology for antimalarial mechanisms.
Practice Questions
Recall
Q: Which Plasmodium species form hypnozoites and can cause relapse? A: P. vivax and P. ovale. Their dormant liver forms require primaquine (or tafenoquine) for radical cure.
Understanding
Q: Explain why P. falciparum causes the most severe disease. A: It infects red cells of all ages (producing very high parasitaemia) and makes infected cells adhere to and sequester in small blood vessels. This microvascular obstruction, plus inflammatory injury, drives cerebral malaria, acidosis, and organ failure that the other species rarely cause.
Application
Q: A vomiting, confused patient has a film showing 6% P. falciparum parasitaemia. What is the immediate treatment and why? A: Intravenous artesunate, immediately, because this is severe malaria (impaired consciousness plus hyperparasitaemia). Oral therapy is inappropriate in a vomiting, drowsy patient, and artesunate reduces mortality more than quinine. Add glucose monitoring and critical-care support.
Analysis
Q: A traveller with confirmed P. vivax is treated with chloroquine, improves, but returns two months later with the same illness. What happened and how should the first course have differed? A: This is relapse from hypnozoites that chloroquine (a blood schizonticide) does not kill. The initial treatment should have included primaquine for radical cure, given after confirming normal G6PD activity. The recurrence is a relapse, not reinfection or resistance.
FAQ
How soon after a mosquito bite do symptoms start? Usually 7–30 days. Falciparum tends toward the shorter end; vivax and ovale can appear months later because of hypnozoites, and prophylaxis can delay onset. Any fever within a year of travel to an endemic area warrants testing.
Can I get malaria if I took antimalarial tablets? Yes — no prophylaxis is 100% effective, and missed doses or poor absorption lower protection. Prophylaxis reduces risk substantially but never removes the need to investigate fever after travel.
Is malaria contagious from person to person? No, not through ordinary contact. It spreads via Anopheles mosquito bites. Rare exceptions include blood transfusion, organ transplant, shared needles, and mother-to-fetus (congenital) transmission.
Why is a blood film still used when rapid tests exist? Microscopy identifies the species and measures parasite density, both of which guide treatment and severity assessment. Rapid tests are faster and useful for screening but cannot quantify parasites and can miss low-density or hrp2-deleted infections.
Does having malaria once make you immune? Only partially, and only with repeated exposure. People in high-transmission areas develop partial immunity that limits severity, but it wanes without ongoing exposure — which is why travellers and returning expatriates are highly vulnerable.
Are the new malaria vaccines a cure or a shield? They are preventive tools, not treatments. RTS,S and R21 reduce the risk and severity of falciparum malaria in children and are deployed alongside — not instead of — bed nets, spraying, and prompt treatment.
Quick Revision
- Cause: Plasmodium protozoa via female Anopheles mosquito bite; five human species.
- P. falciparum = deadliest (cerebral malaria, high parasitaemia); P. vivax = relapse via hypnozoites.
- Life cycle: liver stage (silent) then blood stage (fever from schizont rupture).
- Diagnosis: thick + thin blood films (gold standard); RDTs for rapid screening; repeat films before excluding.
- Uncomplicated falciparum: ACT. Severe malaria: IV artesunate immediately.
- Vivax/ovale: treat blood stage plus primaquine for radical cure — check G6PD first.
- Prevention: bed nets, indoor spraying, chemoprophylaxis for travellers, RTS,S/R21 vaccines.
- Golden rule: fever in a returned traveller is malaria until proven otherwise.